OCTN2-targeted and ROS-responsive hybrid polymeric micelles for oral delivery of docetaxel

Key Points

• Hybrid polymeric micelles successfully deliver docetaxel, enhancing treatment efficacy.
• Micelles demonstrate significant targeting efficiency to OCTN2, crucial for drug uptake.
• The formulation involves optimizing ROS responsiveness to improve drug release in response to cellular stress.
• Potential implications include improved cancer treatment strategies, indicated by enhanced bioavailability.